Taclonex (calcipotriene hydrate and betamethasone dipropionate) topical suspension
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Taclonex (calcipotriene hydrate and betamethasone dipropionate) topical suspension, covering 2018-03-07 to 2018-03-07. Get the full timeline:
Most recent: Clinical Trial Update: BE Study of Calcipotriene Hydrate and Betamethasone Dipropionate Topical Suspension in the Treatment of Scalp Psoriasis [Phase 1]